These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 7866703)

  • 1. The 5' noncoding region and virulence of poliovirus vaccine strains.
    Macadam AJ; Stone DM; Almond JW; Minor PD
    Trends Microbiol; 1994 Nov; 2(11):449-54. PubMed ID: 7866703
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Attenuation and reversion of the Sabin vaccine strains of poliovirus.
    Minor PD
    Dev Biol Stand; 1993; 78():17-26. PubMed ID: 8388828
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Characterization of CHAT and Cox type 1 live-attenuated poliovirus vaccine strains.
    Martín J; Minor PD
    J Virol; 2002 Jun; 76(11):5339-49. PubMed ID: 11991962
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nucleic acid sequence of the region of the genome encoding capsid protein VP1 of neurovirulent and attenuated type 3 polioviruses.
    Stanway G; Cann AJ; Hauptmann R; Mountford RC; Clarke LD; Reeve P; Minor PD; Schild GC; Almond JW
    Eur J Biochem; 1983 Oct; 135(3):529-33. PubMed ID: 6311539
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Point mutations involved in the attenuation/neurovirulence alternation in type 1 and 2 oral polio vaccine strains detected by site-specific polymerase chain reaction.
    Guillot S; Otelea D; Delpeyroux F; Crainic R
    Vaccine; 1994 May; 12(6):503-7. PubMed ID: 8036823
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Genetic basis of attenuation of the Sabin oral poliovirus vaccines.
    Minor PD; Macadam AJ; Stone DM; Almond JW
    Biologicals; 1993 Dec; 21(4):357-63. PubMed ID: 8024751
    [No Abstract]   [Full Text] [Related]  

  • 7. Reversion to neurovirulence of the live-attenuated Sabin type 3 oral poliovirus vaccine.
    Cann AJ; Stanway G; Hughes PJ; Minor PD; Evans DM; Schild GC; Almond JW
    Nucleic Acids Res; 1984 Oct; 12(20):7787-92. PubMed ID: 6093054
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Studies on the attenuation of the Sabin type 3 oral polio vaccine.
    Almond JW; Westrop GD; Evans DM; Dunn G; Minor PD; Magrath D; Schild GC
    J Virol Methods; 1987 Aug; 17(1-2):183-9. PubMed ID: 2822753
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Genetic stability and instability of the cis-acting control element of the 5' untranslated region of the poliovirus RNA.
    Agol VI
    Dev Biol Stand; 1993; 78():11-6. PubMed ID: 8388821
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Strategy for construction of live picornavirus vaccines.
    Nomoto A; Iizuka N; Kohara M; Arita M
    Vaccine; 1988 Apr; 6(2):134-7. PubMed ID: 2838985
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Correlation of RNA secondary structure and attenuation of Sabin vaccine strains of poliovirus in tissue culture.
    Macadam AJ; Ferguson G; Burlison J; Stone D; Skuce R; Almond JW; Minor PD
    Virology; 1992 Aug; 189(2):415-22. PubMed ID: 1641974
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Reversion of the attenuated and temperature-sensitive phenotypes of the Sabin type 3 strain of poliovirus in vaccinees.
    Macadam AJ; Arnold C; Howlett J; John A; Marsden S; Taffs F; Reeve P; Hamada N; Wareham K; Almond J
    Virology; 1989 Oct; 172(2):408-14. PubMed ID: 2552655
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Translation deficiency of the Sabin type 3 poliovirus genome: association with an attenuating mutation C472----U.
    Svitkin YV; Cammack N; Minor PD; Almond JW
    Virology; 1990 Mar; 175(1):103-9. PubMed ID: 2155504
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Laboratory tests for live attenuated poliovirus vaccines.
    Wood DJ; Macadam AJ
    Biologicals; 1997 Mar; 25(1):3-15. PubMed ID: 9167004
    [TBL] [Abstract][Full Text] [Related]  

  • 15. RNA sequence variants in live poliovirus vaccine and their relation to neurovirulence.
    Chumakov KM; Norwood LP; Parker ML; Dragunsky EM; Ran YX; Levenbook IS
    J Virol; 1992 Feb; 66(2):966-70. PubMed ID: 1309923
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Genetic basis of the neurovirulence of type 1 polioviruses isolated from vaccine-associated paralytic patients.
    Li J; Zhang LB; Yoneyama T; Yoshida H; Shimizu H; Yoshii K; Hara M; Nomura T; Yoshikura H; Miyamura T; Hagiwara A
    Arch Virol; 1996; 141(6):1047-54. PubMed ID: 8712922
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Genetic basis of attenuation of the Sabin type 2 vaccine strain of poliovirus in primates.
    Macadam AJ; Pollard SR; Ferguson G; Skuce R; Wood D; Almond JW; Minor PD
    Virology; 1993 Jan; 192(1):18-26. PubMed ID: 8390752
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mutations in Sabin 2 strain of poliovirus and stability of attenuation phenotype.
    Rezapkin GV; Fan L; Asher DM; Fibi MR; Dragunsky EM; Chumakov KM
    Virology; 1999 May; 258(1):152-60. PubMed ID: 10329577
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Molecular mechanisms of attenuation of the Sabin strain of poliovirus type 3.
    Guest S; Pilipenko E; Sharma K; Chumakov K; Roos RP
    J Virol; 2004 Oct; 78(20):11097-107. PubMed ID: 15452230
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Poliovirus translation: a paradigm for a novel initiation mechanism.
    Sonenberg N; Pelletier J
    Bioessays; 1989 Nov; 11(5):128-32. PubMed ID: 2556117
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.